澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ACRUX LTD

0.010

+0.00111.11%

成交量：23.25萬

成交額：2,325

市值：589.68萬

市盈率：-1.73

高：0.010

開：0.010

低：0.010

收：0.009

52周最高：0.021

52周最低：0.009

股本：5.90億

流通股本：3.00億

量比：0.27

換手率：0.08%

股息：- -

股息率：- -

每股收益(TTM):-0.006

每股收益(LYR):-0.017

淨資產收益率：-102.19%

總資產收益率：-57.22%

市淨率：4.91

市盈率(LYR):-0.59

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+2.85%

資金流向

資金流入：

資金流出：

新聞資訊

匈牙利吉瑞宣佈修訂協議授予其澳大利亞市場獨家商業化權利

匈牙利吉瑞與Acrux就2013年透皮雌二醇噴霧Lenzetto在澳大利亞市場的許可協議達成延期共識

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/ACR.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","market":"AU","secType":"STK","nameCN":"ACRUX LTD","latestPrice":0.01,"timestamp":1787638320000,"preClose":0.009,"halted":0,"volume":232468,"delay":0,"changeRate":0.11111111111111122,"nameEN":"ACRUX LTD","floatShares":300389644,"shares":589677802,"eps":-0.005785,"marketStatus":"未開盤","change":0.001,"latestTime":"08-25 16:12:00 AEST","open":0.01,"high":0.01,"low":0.01,"amount":2325,"amplitude":0,"askPrice":0.011,"askSize":100000,"bidPrice":0.01,"bidSize":575224,"shortable":3,"etf":0,"ttmEps":-0.005785,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.009,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.266659,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACR.AU","preClose":0.01,"auctionPrice":0.009,"auctionVolume":12130,"auction":3,"marketStatus":"盘后竞价","timestamp":1787551260130}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","floatShares":300389644,"roa":"-57.22%","roe":"-102.19%","lyrEps":-0.016881,"volumeRatio":0.266659,"shares":589677802,"dividePrice":0,"high":0.01,"amplitude":0,"preClose":0.009,"low":0.01,"week52Low":0.009,"pbRate":"4.91","psRate":"2.10","week52High":0.021,"institutionHeld":0,"latestPrice":0.01,"committee":0.703802,"eps":-0.005785,"divideRate":0,"volume":232468,"delay":0,"ttmEps":-0.005785,"open":0.01,"prevYearClose":0.015,"prevWeekClose":0.01,"prevMonthClose":0.01,"prevQuarterClose":0.012,"fiveDayClose":0.01,"twentyDayClose":0.011,"sixtyDayClose":0.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"ACR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708606800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150467405","title":"匈牙利吉瑞宣佈 修訂協議授予其澳大利亞市場獨家商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1150467405","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150467405?lang=zh_tw&edition=fundamental","pubTime":"2026-05-27 14:35","pubTimestamp":1779863714,"startTime":"0","endTime":"0","summary":"匈牙利吉瑞公司宣布，一项已修订的协议现授予该公司在澳大利亚市场的独家商业化权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","ACR.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174480160","title":"匈牙利吉瑞與Acrux就2013年透皮雌二醇噴霧Lenzetto在澳大利亞市場的許可協議達成延期共識","url":"https://stock-news.laohu8.com/highlight/detail?id=1174480160","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174480160?lang=zh_tw&edition=fundamental","pubTime":"2026-05-27 14:35","pubTimestamp":1779863714,"startTime":"0","endTime":"0","summary":"匈牙利吉瑞制药公司宣布，已与澳大利亚Acrux公司就其2013年签署的、关于透皮雌二醇喷雾Lenzetto在澳大利亚市场的许可协议达成延期协议。双方同意延长该许可协议的有效期，继续在澳大利亚市场推广和销售Lenzetto产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}